MF Global Holdings Ltd. plans to sell up to $150 million in shares and has launched an offer to exchange shares for some senior notes and preferred stock. The brokerage, which has a market ...
Novartis announced the first study results from the phase III PLATINUM clinical development programme assessing the safety and efficacy of QMF149, an investigational, once-daily, fixed dose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results